Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.00% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
BGLC · Dec 31, 2023
BioNexus Gene Lab Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001477932-24-002151General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-13.32% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-10.60% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
11.64% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
13.61% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
-26.54% · CORE · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Sep 30, 20214/6 normalizedLevel 3Dec 31, 20214/6 normalizedLevel 3Mar 31, 20225/6 normalizedLevel 3Jun 30, 20225/6 normalizedLevel 3Sep 30, 20226/6 normalizedLevel 3Dec 31, 20226/6 normalizedLevel 3Mar 31, 20236/6 normalizedLevel 3Jun 30, 20236/6 normalizedLevel 3Sep 30, 20236/6 normalizedAmended as filedDec 31, 20236/6 normalizedLevel 3Mar 31, 20245/5 normalizedLevel 3Jun 30, 20245/5 normalizedLevel 3Sep 30, 20245/5 normalizedLevel 3Dec 31, 20246/8 normalizedLevel 3Mar 31, 20256/7 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20256/7 normalizedLevel 3Dec 31, 20256/9 normalizedLevel 3Mar 31, 20266/7 normalizedLevel 3Jun 30, 20266/7 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 5.25%
- Current
- 0.00%
- Delta
- -5.25%
- Previous
- -35.22%
- Current
- -13.32%
- Delta
- 21.90%
- Previous
- -0.83%
- Current
- -10.60%
- Delta
- -9.76%
- Previous
- 43.38%
- Current
- 11.64%
- Delta
- -31.74%
- Previous
- 13.88%
- Current
- 13.61%
- Delta
- -0.27%
- Previous
- -99.01%
- Current
- -26.54%
- Delta
- 72.47%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · BGLC Fundamental State →Transitioned To · BGLC historical state 2023-09-30 →Transitioned To · BGLC CAPEX_INTENSITY_DECREASED →Transitioned To · BGLC CASH_GENERATION_INCREASED →Transitioned To · BGLC GROWTH_DECREASED →Transitioned To · BGLC INVENTORY_PRESSURE_DECREASED →Transitioned To · BGLC MARGIN_DECREASED →Transitioned To · BGLC PROFITABILITY_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.